Cargando…

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

Fifty years after the recognition of the Li–Fraumeni syndrome (LFS), our perception of cancers related to germline alterations of TP53 has drastically changed: (i) germline TP53 alterations are often identified among children with cancers, in particular soft-tissue sarcomas, adrenocortical carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frebourg, Thierry, Bajalica Lagercrantz, Svetlana, Oliveira, Carla, Magenheim, Rita, Evans, D. Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609280/ https://www.ncbi.nlm.nih.gov/pubmed/32457520 http://dx.doi.org/10.1038/s41431-020-0638-4

Ejemplares similares

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

Reply to Kratz et al.
por: Frebourg, Thierry, et al.
Publicado: (2020)

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2021)

A Novel Variant in the TP53 Gene Causing Li–Fraumeni Syndrome
por: Papadimitriou, Dimitrios T., et al.
Publicado: (2023)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

A novel TP53 tandem duplication in a child with Li–Fraumeni syndrome
por: Xu, Feng, et al.
Publicado: (2022)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
por: Kai, Masaya, et al.
Publicado: (2022)

Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (2000)

Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
por: Haque, Mohammed Moquitul, et al.
Publicado: (2018)

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis
por: Kratz, Christian P., et al.
Publicado: (2021)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
por: Omran, Meis, et al.
Publicado: (2020)

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
por: Calvete, Oriol, et al.
Publicado: (2015)

A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
por: Glazer, Robert I.
Publicado: (2010)

TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
por: Ribi, Sebastian, et al.
Publicado: (2015)

Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family
por: AlHarbi, Musa, et al.
Publicado: (2018)

Cancer spectrum in TP53-deficient golden Syrian hamsters: A new model for Li-Fraumeni syndrome
por: Miao, Jinxin, et al.
Publicado: (2021)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome
por: Taja-Chayeb, Lucia, et al.
Publicado: (2009)

Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
por: Paduano, Francesco, et al.
Publicado: (2021)

Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
por: Rocca, Valentina, et al.
Publicado: (2022)

Simultaneous Occurrence of Germline Pathogenic Allele Variants of TMEM127 and TP53 in a Brazilian Family With Li-Fraumeni Syndrome
por: Lima, Jose Viana, et al.
Publicado: (2021)

A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53)
por: Petry, Vanessa, et al.
Publicado: (2023)

FRI256 The Clinical Impacts Of Bi-allelic Germline Pathogenic Variant In TP53 In Two Patients With Li-Fraumeni Syndrome
por: Petry, Vanessa, et al.
Publicado: (2023)

SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
por: Sánchez-Heras, Ana Beatriz, et al.
Publicado: (2023)

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome
por: Heymann, Steve, et al.
Publicado: (2010)

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
por: Varley, J. M., et al.
Publicado: (1998)

The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
por: Silva, Amanda G, et al.
Publicado: (2014)

Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers
por: Sandoval, Renata Lazari, et al.
Publicado: (2022)

Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

Identification of a TP53 Mutation in a Patient With Li-Fraumeni Syndrome and Not Meeting the Revised Chompret Criteria: A Case Report
por: Iwasaki, Monika, et al.
Publicado: (2023)

Radiation-induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (1999)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
por: Fransson, Åsa, et al.
Publicado: (2016)

Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021)

TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes
por: da Silva, Paula Francinete Faustino, et al.
Publicado: (2022)

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)

The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
por: Li, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7pbk8mtihtnde23kfvqsq8ctk